Диссертация (1140384), страница 23
Текст из файла (страница 23)
Movileanu, B. van den Berg // Nature Structural andMolecular Biology. – 2007. – Vol. 14. – № 11. – P. 1108–1109.39. Bogaerts, P. Detection and characterization of VIM-31, a new variant of VIM-2with Tyr224His and His252Arg mutations, in a clinical isolate of Enterobactercloacae / P. Bogaerts, C. Bebrone, T.D. Huang, W. Bouchahrouf, Y. Degheldre, A.Deplano, K. Hoffmann, Y. Glupczynski // Antimicrobial Agents and Chemotherapy.– 2012.
– Vol. 56, № 6. – P. 3283–3287.40. Bogaerts, P. Evaluation of a DNA microarray for rapid detection of the mostprevalent extended-spectrum β-lactamases, plasmid-mediated cephalosporinases andcarbapenemases in Enterobacteriaceae, Pseudomonas and Acinetobacter / P.Bogaerts, G. Cuzon, S. Evrard, M. Hoebeke, T. Naas, Y. Glupczynski //International journal of antimicrobial agents. – 2016.
– Vol. 48, № 2. – P. 189–193.41. Bohnert, J.A. Determination of real-time efflux phenotypes in Escherichia coliAcrB binding pocket phenylalanine mutants using a 1,2'-dinaphthylamine effluxassay / J.A. Bohnert, S. Schuster, M. Szymaniak-Vits, W.V. Kern // PLoS One. –2011. – Vol. 6, № 6. – e21196.42.
Bolognese, F. Activation and inactivation of Pseudomonas stutzeri methylbenzenecatabolism pathways mediated by a transposable element / F. Bolognese, C. Di149Lecce, E. Galli, P. Barbieri // Applied and Environmental Microbiology. – 1999. –Vol. 65, №5. – P. 1876–1882.43. Boucher, H.W. Bad bugs, no drugs: no ESKAPE! An update from the InfectiousDiseases Society of America / H.W. Boucher, G.H. Talbot, J.S.
Bradley,J.E.Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, J. Bartlett // ClinicalInfection Disease. – 2009. – Vol. 48, № 1. – P. 1–12.44. Boutoille, D. Detection of an IS21 insertion sequence in the mexR gene ofPseudomonas aeruginosa increasing beta-lactam resistance / D. Boutoille, S.Corvec, N. Caroff, C. Giraudeau, E. Espaze, J. Caillon, P. Plesiat, A. Reynaud //FEMS Microbiology Letters. – 2004.
– Vol. 230, №1. – P. 143–146.45. Braz, V.S. Mutations in NalC induce MexAB-OprM overexpression resulting inhigh level of aztreonam resistance in environmental isolates of Pseudomonasaeruginosa / V.S. Braz, J.P. Furlan, A.F. Fernandes, E.G. Stehling // FEMSMicrobiology Letters. – 2016. – Vol. 363, № 16. – fnw166.46. Breidenstein, E.B. Complex ciprofloxacin resistome revealed by screening aPseudomonas aeruginosa mutant library for altered susceptibility / E.B.Breidenstein, B.K. Khaira, I. Wiegand, J.
Overhage, R.E.W. Hancock //Antimicrobial Agents and Chemotherapy. – 2008. – № 52. – P. 4486–4491.47. Breidenstein, E.B. Pseudomonas aeruginosa: all roads lead to resistance / E.B.Breidenstein, C. de la Fuente-Nunez, R.E. Hancock // Trends in microbiology. –2011. – Vol. 19, № 8. – P. 419–426.48. Brewer, S.C. Ventilator‐associated pneumonia due to Pseudomonas aeruginosa /S.C. Brewer, R.G. Wunderink, C.B. Jones, K.V.
Leeper // CHEST. –1996. – № 109.– P. 1019–1029.49. Buscher, K.H. Imipenem resistance in Pseudomonas aeruginosa resulting fromdiminished expression of an outer membrane protein / K.H. Buscher, W. Cullmann,W. Dick, W. Opferkuch // Antimicrobial Agents and Chemotherapy. – 1987. – Vol.31, № 5. – P. 703–708.15050.
Bustin, S.A. The MIQE guidelines: minimum information for publication ofquantitative real-time PCR experiments / S.A. Bustin, V. Benes, J.A. Garson, J.Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L.Shipley, J. Vandesompele, C.T. Wittwer // Clinical Chemistry. – 2009. – Vol. 55, №4. – P. 611–622.51. Cai, J.C. Detection of OmpK36 Porin Loss in Klebsiella spp. by Matrix-AssistedLaser Desorption Ionization–Time of Flight Mass Spectrometry / J.C. Cai, Y.Y. Hu,R. Zhang, H.W. Zhou, G.X. Chen // Journal of Clinical Microbiology.
– 2012. –Vol. 50, №6. – P. 2179–2182.52. Caille, O. A Copper-activated two-component system interacts with zinc andimipenem resistance in Pseudomonas aeruginosa / O. Caille, C. Rossier, K. Perron// Journal of Bacteriology. – 2007. – Vol. 189, № 13. – P. 4561–4568.53. Carrara-Marroni, F.E. Emergence and spread of KPC-2-producing Pseudomonasaeruginosa isolates in a Brazilian teaching hospital // F.E. Carrara-Marroni, R.Cayo, A.P. Streling, A.C.
da Silva, R.L. Palermo, P. Romanin, E. Venancio, M.R.Perugini, M. Pelisson, A.C. Gales // Journal of Global Antimicrobial Resistance. –2015. – Vol. 3, № 4. – P. 304–306.54. Carrer, A. Use of ChromID extended-spectrum beta-lactamase medium fordetecting carbapenemase-producing Enterobacteriaceae // A. Carrer, N. Fortineau, P.Nordmann // Journal of Clinical Microbiology. – 2010. – Vol. 48, № 5.
– P. 1913–1914.55. Castanheira, M. Epidemiology and carbapenem resistance mechanisms ofcarbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in14 European and Mediterranean countries / M. Castanheira, L.M. Deshpande, A.Costello, T.A. Davies, R.N. Jones // Journal of Antimicrobial Chemotherapy. –2014.
– Vol. 69, № 7. – P. 1804–1814.56. Cayci,Y.T.Investigationofplasmid-mediatedquinoloneresistanceinPseudomonas aeruginosa clinical isolates / Y.T. Cayci, A.Y. Coban, M. Gunaydin //Indian Journal of Medical Microbiology. – 2014. – Vol. 32, № 3. – P. 285–289.15157. Centers for Disease Control and Prevention [Электронный ресурс] // Antibioticresistance threats in the United States, 2013.– P. 69–71. – URL:https://www.cdc.gov/drugresistance/threat-report-2013/index.html(датаобращения: 15.12.2017).58. Chalhoub, H. High-level resistance to meropenem in clinical isolates ofPseudomonas aeruginosa in the absence of carbapenemases: role of active effluxand porin alterations / H. Chalhoub, Y.
Saenz, H. Rodriguez-Villalobos, O. Denis,B.C. Kahl, P.M. Tulkens, F. Van Bambeke // International Journal of AntimicrobialAgents. – 2016. – Vol. 48, № 6. – P. 740–743.59. Chevalier, S. Sequence diversity of the OprD protein of environmentalPseudomonas strains / S. Chevalier, J. Bodilis, T. Jaouen, S. Barray, M.G.J.Feuilloley, N.
Orange // Environmental Microbiology. – 2007. – № 9. – P. 824–835.60. Chevalier, S. Structure, function and regulation of Pseudomonas aeruginosa porins// S. Chevalier, E. Bouffartigues, J. Bodilis, O. Maillot, O. Lesouhaitier, M.G.J.Feuilloley, N.
Orange, A. Dufour, P. Cornelis // FEMS Microbiology Reviews. –2017. – Vol. 41, № 5. – P. 698–722.61. Chong, P.M. MALDI-TOF MS detection of carbapenemase activity in clinicalisolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacterbaumannii compared against the Carba-NP assay / P.M. Chong, S.J. McCorrister,M.S. Unger, D.A. Boyd, M.R. Mulvey, G.R. Westmacott // Journal ofMicrobiological Methods. – 2015. - № 111. – P. 21–23.62. Cohen Stuart, J. Guideline for phenotypic screening and confirmation ofcarbapenemases in Enterobacteriaceae / J. Cohen Stuart, M.A.
Leverstein-Van Hall// International Journal of Antimicrobial Agents. – 2010. – Vol. 36, № 3. – P. 205–210.63. Colomb-Cotinat, M. Estimating the morbidity and mortality associated withinfections due to multidrug-resistant bacteria (MDRB), France, 2012 [Электронныйресурс] / M. Colomb-Cotinat, J.
Lacoste, C. Brun-Buisson, V. Jarlier, B. Coignard,152S. Vaux // Antimicrobial Resistance and Infection Control. – 2016. – Vol. 5, № 56. –Режим доступа: https://www.ncbi.nlm.nih.gov/pubmed/27999665.64. Cox, G. Intrinsic antibiotic resistance: mechanisms, origins, challenges andsolutions / G. Cox, G.D. Wright // International Journal of Medical Microbiology.
–2013. – Vol. 303, №. 6. – P. 287–292.65. Dallenne, C. Development of a set of multiplex PCR assays for the detection ofgenes encoding important beta-lactamases in Enterobacteriaceae / C. Dallenne, A.Da Costa, D. Decre, C. Favier, G. Arlet // Journal of Antimicrobial Chemotherapy. –2010. – Vol. 65, №3. – P. 490–495.66.
Daugelavicius, R. Stages of polymyxin B interaction with the Escherichia coli cellenvelope / R. Daugelavicius, E. Bakiene, D.H. Bamford // Antimicrobial Agents andChemotherapy. – 2000. – № 44. – P. 2969–2978.67. Delmar, J.A. Bacterial multi-drug efflux transporters / J.A. Delmar, C.C. Su, E.W.Yu // Annual review of biophysics. – 2014. – № 43. – P. 93–117.68. Diene, S.M.
ISPa46, a novel insertion sequence in the oprD porin gene of animipenem-resistant Pseudomonas aeruginosa isolate from a cystic fibrosis patient inMarseille, France / S.M. Diene, T. L'homme, S. Bellulo, N. Stremler, J.C. Dubus, L.Mely, S. Leroy, N. Degand, J.M. Rolain // International Journal of AntimicrobialAgents. – 2013. – Vol. 42, № 3. – P.
268–271.69. Dieppois, G. The transcriptional regulator CzcR modulates antibiotic resistance andquorum sensing in Pseudomonas aeruginosa // G. Dieppois, V. Ducret, O. Caille, K.Perron // PLoS One. – 2012. – V. 7, №5. – e38148.70. Djordjevic, Z. Nosocomial urinary tract infections caused by Pseudomonasaeruginosa and Acinetobacter species: Sensitivity to antibiotics and risk factors / Z.Djordjevic, M.
M. Folic, Z. Zivic, V. Markovic, S.M. Jankovic // American journalof infection control. – 2013. – Vol. 41, № 12. – P. 1182–1187.71. Doi,Y. 16S ribosomal RNA methylation: emerging resistance mechanism againstaminoglycosides / Y. Doi, Y. Arakawa // Clinical Infectious Diseases. – 2007. – №45. – P. 88–94.15372. Doring, G.
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: aEuropean consensus / G. Doring, S.P. Conway, H.G. Heijerman, M.E. Hodson, N.Hoiby, A. , D.J. Touw // European Respiratory Journal. – 2000. – Vol. 16, № 4. – P.749–767.73. Dotsch A. Genomewide identification of genetic determinants of antimicrobial drugresistance in Pseudomonas aeruginosa / A. Dotsch, T. Becker, C. Pommerenke, Z.Magnowska, L.S. Jansch Haussler // Antimicrobial Agents and Chemotherapy.
–2009. – № 53. – P. 2522–2531.74. Dreier, J. Interaction of antibacterial compounds with RND effux pumps inPseudomonas aeruginosa [Электронный ресурс] / J. Dreier, P. Ruggerone //Frontiers in Microbiology. – 2015. – Vol. 6, № 660. – Режим доступа:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495556/.75. Edelstein,M.V.SpreadofextensivelyresistantVIM-2-positiveST235Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinalepidemiological and clinical study / M.V. Edelstein, E.N. Skleenova, O.V.Shevchenko, J.W.
D'souza, D.V. Tapalski, I.S. Azizov, M.V. Sukhorukova, R.A.Pavlukov, R.S. Kozlov, M.A. Toleman, T.R. Walsh // Lancet Infectious Diseases. –2013. – Vol. 13, №10. – P. 867–876.76. Ehmann, D.E. Kinetics of avibactam inhibition against class A, C, and D βLactamases / D.E. Ehmann, H. Jahic, P.L. Ross, R.F. Gu, J. Hu, T.F. DurandReville, S. Lahiri, J. Thresher, S.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
